UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	May 5, 2023 4:30 P.M.

Form:	S-3
CIK: 0001347178 Company Name: Vanda Pharmaceuticals Inc. File Number: 333-269654